[Prenatal interventional therapy in two cases with critical pulmonary stenosis or pulmonary atresia with intact

C C Pang1, W Pan, Z W Zhang

  • 1Department of Maternal-Fetal Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Province Key Laboratory of Structural Heart Disease, Guangzhou 510080, China.

Insights

Fetal pulmonary valvuloplasty (FPV) is a safe and effective procedure for fetuses with pulmonary atresia or stenosis, improving heart development and potentially preventing postnatal surgeries.

Area of Science:

  • Cardiology
  • Fetal Medicine
  • Interventional Cardiology

Background:

  • Pulmonary atresia with intact ventricular septum (PA-IVS) and critical pulmonary stenosis with intact ventricular septum (CPS-IVS) are severe congenital heart defects.
  • Early intervention may improve outcomes by promoting right ventricular development.

Purpose of the Study:

  • To explore criteria for case selection, technical aspects, and outcomes of fetal pulmonary valvuloplasty (FPV).
  • To evaluate the impact of FPV on fetal cardiac development and hemodynamics.

Main Methods:

  • Two cases (PA-IVS and CPS-IVS) underwent ultrasound-guided trans-abdominal FPV at 28 weeks gestation.
  • Echocardiography monitored pulmonary valve function, right ventricular development, and hemodynamics post-procedure.

Main Results:

  • FPV was technically successful, improving pulmonary valve opening in both cases.
  • One case experienced restenosis, while the other showed significant improvement in cardiac function and hemodynamics post-FPV and postnatal intervention.
  • Both fetuses were born alive, with one requiring further postnatal procedures.

Conclusions:

  • FPV is safe and effective in the second and third trimesters, promoting fetal heart development.
  • FPV may reduce the need for postnatal single-ventricle palliation and prevent fetal heart failure or death.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
998
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
639
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
633
Overview of Pulmonary Circulation01:19

Overview of Pulmonary Circulation

The pulmonary circulation is a vital system in our body that acts as a bridge between the respiratory and cardiovascular systems. It serves as a transport network for deoxygenated blood from the heart to the lungs and then returns oxygen-rich blood back to the heart.
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
3.3K